For targeted cancer therapy, attempts have been made to generate conjugates of membrane incorporating molecule DSPE-PEG200 and Hyaluronan (HA), a CD44-specific ligand, which are then self-assembled into the phospholipid bilayer of milk exosomes [138]. Here, CD44 is linked to cancer.